Search research articles
Contact Us
Filters
Showing results (21-30 of 84) with videos related to
Page
of 9
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center
|
October 8, 2021
Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With <i>BRAF</i> V600E-Mutated Gliomas
Michael J Fusco, Yolanda Piña, Robert J Macaulay, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 20, 2013
Bevacizumab use for recurrent high-grade glioma at McGill University Hospital
Solmaz Sahebjam, Evgenia Garoufalis, Marie-Christine Guiot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
Reply to J. Wei et al
Nancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
Scientific Reports
|
October 13, 2021
Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements
Sarah C Brüningk, Jeffrey Peacock, Christopher J Whelan, et al.
American Journal of Clinical Oncology
|
April 24, 2014
Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases
Kamran A Ahmed, Siriporn Sarangkasiri, Prakash Chinnaiyan, et al.
Scientific Reports
|
March 16, 2022
Author Correction: Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements
Sarah C Brüningk, Jeffrey Peacock, Christopher J Whelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2021
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study
Nancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
NPJ Breast Cancer
|
November 18, 2023
Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data
Nancy U Lin, Priya Kumthekar, Solmaz Sahebjam, et al.
Journal of Neurosurgery. Case Lessons
|
September 21, 2022
NTRK3 gene fusion in an adult ganglioglioma: illustrative case
Sebastian Rubino, John Lynes, Paul McBride, et al.
Clinical Neurology and Neurosurgery
|
April 7, 2017
Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomy
Anastasia Groshev, Devang Padalia, Sephalie Patel, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 84) with videos related to
Sort By:
Page
of 9
Cancer Control : Journal of the Moffitt Cancer Center
|
October 8, 2021
Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With <i>BRAF</i> V600E-Mutated Gliomas
Michael J Fusco, Yolanda Piña, Robert J Macaulay, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
February 20, 2013
Bevacizumab use for recurrent high-grade glioma at McGill University Hospital
Solmaz Sahebjam, Evgenia Garoufalis, Marie-Christine Guiot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
Reply to J. Wei et al
Nancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
Scientific Reports
|
October 13, 2021
Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements
Sarah C Brüningk, Jeffrey Peacock, Christopher J Whelan, et al.
American Journal of Clinical Oncology
|
April 24, 2014
Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases
Kamran A Ahmed, Siriporn Sarangkasiri, Prakash Chinnaiyan, et al.
Scientific Reports
|
March 16, 2022
Author Correction: Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements
Sarah C Brüningk, Jeffrey Peacock, Christopher J Whelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2021
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study
Nancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
NPJ Breast Cancer
|
November 18, 2023
Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data
Nancy U Lin, Priya Kumthekar, Solmaz Sahebjam, et al.
Journal of Neurosurgery. Case Lessons
|
September 21, 2022
NTRK3 gene fusion in an adult ganglioglioma: illustrative case
Sebastian Rubino, John Lynes, Paul McBride, et al.
Clinical Neurology and Neurosurgery
|
April 7, 2017
Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomy
Anastasia Groshev, Devang Padalia, Sephalie Patel, et al.
Page
of 9